Biosimilar Knowledge Among Oncology/Hematology Team Members in Colorado, USA: An Educational Initiative and Follow-Up Survey.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

No data exist regarding oncology/hematology team members' knowledge of and views on biosimilars in Colorado, USA. Published research has suggested that health professionals may have a poor understanding of many issues related to biosimilars.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): BioDrugs

Title: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Publisher: Springer Science and Business Media LLC

ISSN (Electronic): 1179-190X

ISSN (Print): 1173-8804

Publication date (Electronic): Oct 2018

Volume: 32

Issue: 5

Affiliations

[1 ] Complex Mechanisms of Disease, Aging and Trauma (CMDAT) Research Foundation, PO Box 460722, Denver, CO, 80246, USA. dr.ismailov@cmdat.org.

[2 ] Complex Mechanisms of Disease, Aging and Trauma (CMDAT) Research Foundation, PO Box 460722, Denver, CO, 80246, USA.

Article

Publisher Item ID: 10.1007/s40259-018-0301-6

DOI: 10.1007/s40259-018-0301-6

PubMed ID: 30120705

SO-VID: fa773cb7-fc8c-4157-918e-94327ea59fc1

History

Data availability:

Comments

Comment on this article

scite_

Cited by 5

See all cited by